Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

2 Meme Stocks That Could Go Parabolic This Year
2 Meme Stocks That Could Go Parabolic This Year

If a forgotten stock has gone parabolic and skyrockets in value, that usually means it has captured the attention of retail investors. Stocks like GameStop and AMC Entertainment are great examples

Does Disney Have a Hulu Problem?
Does Disney Have a Hulu Problem?

Since Netflix (NASDAQ: NFLX) reported lower quarter-over-quarter subscriber numbers, other streaming stocks have been under a microscope. But it's not just subscriber numbers that are being called

Everyone Is Talking About This Stock. Is It a Good Long-Term Option?
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?

If you'd forgotten about International Business Machines (NYSE: IBM), you're not alone, and you're forgiven. It used to be royalty within the technology arena, but the company's dominance and

Home Depot and Lowe's Just Shed Light on the Broader Economy. Should Investors Worry?
Home Depot and Lowe's Just Shed Light on the Broader Economy. Should Investors Worry?

Home Depot (NYSE: HD) and Lowe's (NYSE: LOW) were beneficiaries of a massive shift in consumer spending at the pandemic's onset. Forced to work, learn, and entertain at home, people spent on home

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
3 Winners and 2 Losers in a Stock Market Downturn
3 Winners and 2 Losers in a Stock Market Downturn

The stock market has been on a downward trajectory since the start of 2022. The S&P 500 has flirted with a 20% decline, which would meet the dictionary definition of a bear market. While it can be

As a Millennial, I'm Not Relying on Social Security. Here's What I'm Doing Instead
As a Millennial, I'm Not Relying on Social Security. Here's What I'm Doing Instead

Social Security is a benefit millions of Americans look forward to enjoying as they enter their golden years. But for millennials -- that is, those born between 1981 and 1996 -- Social Security has

3 Reasons Why Moderna Stock Is so Cheap Right Now
3 Reasons Why Moderna Stock Is so Cheap Right Now

Moderna's (NASDAQ: MRNA) stock is in poor shape. So far this year, it's down more than 44% and its valuation multiples are slumping. On the bright side, people can buy the shares far more cheaply

3 Unstoppable Growth Stocks That Are Too Cheap to Ignore
3 Unstoppable Growth Stocks That Are Too Cheap to Ignore

Growth stocks have fallen out of favor with investors in 2022 due to inflation, rising interest rates, and other headwinds. In this environment, many are instead seeking safety in value stocks and

2 Stocks to Buy and Hold Through Any Market Downturn
2 Stocks to Buy and Hold Through Any Market Downturn

Some investments are better equipped to survive recessions and market corrections than others. A strong balance sheet helps a lot, and it's even better if management is willing and able to adapt to

This Growing Retail Company Has a $500 Billion Market Opportunity
This Growing Retail Company Has a $500 Billion Market Opportunity

Stitch Fix's (NASDAQ: SFIX) stock has taken a beating over the past year, but there are positive signs ahead. In this video clip from "The Virtual Opportunities Show" on Motley Fool Live, recorded

How to Score Up to an Extra $2,537 per Social Security Check
How to Score Up to an Extra $2,537 per Social Security Check

In 2022, the typical retiree claiming Social Security can expect a monthly benefit of $1,657 -- $2,537 less than the maximum possible benefit of $4,194. The good news is that you can work toward a

Prediction: These 3 Warren Buffett Stocks Will Be the Biggest Winners This Decade
Prediction: These 3 Warren Buffett Stocks Will Be the Biggest Winners This Decade

There's an old adage that "hindsight is 20/20." Of course it is! Most people can look back and see clearly what worked and what didn't. Foresight, on the other hand, is hard. Really, really hard.

If

On the Fence About Crypto? 1 Simple Question to Ask Yourself
On the Fence About Crypto? 1 Simple Question to Ask Yourself

Crypto has taken the world by storm over the past two years, but some cryptocurrencies have lost at least half their value in a matter of months. This most recent crash has caused many investors to

3 Reasons I'm Not Worried About a Stock Market Crash
3 Reasons I'm Not Worried About a Stock Market Crash

Investing when the market is rocky can be daunting. The S&P 500 has been hovering around bear market territory, falling more than 14% since its peak in early January.

Although stock prices have

Warren Buffett's 4 Highest-Yielding Dividend Stocks
Warren Buffett's 4 Highest-Yielding Dividend Stocks

Since taking the reins as CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965, Warren Buffett has put on a moneymaking clinic for Wall Street. He's created over $680 billion in value for

In Your 40s With No Retirement Savings? Here's What to Do.
In Your 40s With No Retirement Savings? Here's What to Do.

It's not uncommon for younger workers to neglect their retirement savings. After all, many people spend the bulk of their 20s paying off student loans and saving for a home. And they spend their 30s

Who's Ready for a 23% Cut to Their Social Security Benefit?
Who's Ready for a 23% Cut to Their Social Security Benefit?

Social Security is, arguably, the U.S.'s most successful and relied-upon social program. When national pollster Gallup surveyed retired beneficiaries and future retirees in April, it found that 89%

DGAP-News: MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022
DGAP-News: MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022
DGAP-News: MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Stitch Fix (SFIX) Q3 2022 Earnings Call Transcript
Stitch Fix (SFIX) Q3 2022 Earnings Call Transcript

Image source: The Motley Fool.

Stitch Fix (NASDAQ: SFIX)Q3 2022 Earnings CallJun 09, 2022, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

DGAP-News: Biotest AG: Biotest achieves important milestone in Phase III study in acquired fibrinogen deficiency
DGAP-News: Biotest AG: Biotest achieves important milestone in Phase III study in acquired fibrinogen deficiency
DGAP-News: Biotest AG: Biotest achieves important milestone in Phase III study in acquired fibrinogen deficiency
DocuSign (DOCU) Q1 2023 Earnings Call Transcript
DocuSign (DOCU) Q1 2023 Earnings Call Transcript

Image source: The Motley Fool.

DocuSign (NASDAQ: DOCU)Q1 2023 Earnings CallJun 09, 2022, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Graham Corporation (GHM) Q4 2022 Earnings Call Transcript
Graham Corporation (GHM) Q4 2022 Earnings Call Transcript

Image source: The Motley Fool.

Graham Corporation (NYSE: GHM)Q4 2022 Earnings CallJun 09, 2022, 11:00 a.m. ET

Debbie Pawlowski

Continue reading

Source Fool.com

European Central Bank To Hike Rates For First Time in Over a Decade
European Central Bank To Hike Rates For First Time in Over a Decade

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

All buono things